HER2 in metastatic colorectal cancer: a new to target to remember.

Bitar, Lynn; Zouein, Joseph; Haddad, Fady Gh; Eid, Roland; Kourie, Hampig R

HER2 in metastatic colorectal cancer: a new to target to remember.

Bitar, Lynn; Zouein, Joseph; Haddad, Fady Gh; Eid, Roland; Kourie, Hampig R.

Afiliación

Bitar L; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Zouein J; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Haddad FG; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Eid R; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.
Kourie HR; Department of Hematology & Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon.

Biomark Med ; 15(2): 135-138, 2021 02.

Article en En | MEDLINE | ID: mdl-33442995

Asunto(s)

Neoplasias Colorrectales; Trastuzumab; Biomarcadores de Tumor; Humanos; Receptor ErbB-2

Palabras clave

HER2; TDM-1; amplification; colorectal cancer; lapatinib; overexpression; pertuzumab; trastuzumab; trastuzumab deruxtecan; tucatinib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Trastuzumab Límite: Humans Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2021 Tipo del documento: Article País de afiliación: Líbano Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google